Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression von Seymour, John F, Marcus, Robert, Davies, Andrew, Gallop-Evans, Eve, Grigg, Andrew, Haynes, Andrew, Herold, Michael, Illmer, Thomas, Nilsson-Ehle, Herman, Sökler, Martin, Dünzinger, Ulrich, Nielsen, Tina, Launonen, Aino, Hiddemann, Wolfgang

Volltext

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study von Launonen, Aino, Hiddemann, Wolfgang, Duenzinger, Ulrich, Fingerle-Rowson, Günter, Nielsen, Tina, Marcus, Robert

Volltext

Abstract CT210: Trial in Process: Phase 1 studies of BI 1701963, a SOS1::KRAS Inhibitor, in combination with MEK inhibitors, irreversible KRASG12C inhibitors or irinotecan von Hofmann, Marco H., Lu, Hengyu, Duenzinger, Ulrich, Gerlach, Daniel, Trapani, Francesca, Machado, Annette A., Daniele, Joseph R., Waizenegger, Irene, Gmachl, Michael, Rudolph, Dorothea, Vellano, Christopher P., Marotti, Marcelo, Vucenovic, Vitomir, Heffernan, Timothy P., Marszalek, Joseph R., Petronczki, Mark P., Kraut, Norbert

Volltext

Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems von Schulz, Miriam, Bialleck, Heike, Thorausch, Kristin, Bug, Gesine, Dünzinger, Ulrich, Seifried, Erhard, Bönig, Halvard

Volltext

Abstract LB_A16: DareonTM-5: An open-label Phase II trial of BI 764532, a DLL3-targeting T cell engager, in patients with relapsed/refractory small cell lung cancer or other neuroe... von Gambardella, Valentina, Greystoke, Alastair, Reck, Martin, Liu, Meiruo, Mueller, Martha, Duenzinger, Ulrich, Bergsland, Emily B, Owonikoko, Taofeek

Volltext

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression (vol... von Seymour, John F., Marcus, Robert, Davies, Andrew, Gallop-Evans, Eve, Grigg, Andrew, Haynes, Andrew, Herold, Michael, Illmer, Thomas, Nilsson-Ehle, Herman, Soekler, Martin, Duenzinger, Ulrich, Nielsen, Tina, Launonen, Aino, Hiddemann, Wolfgang

Volltext

The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany von Hofmann, Sarah, Himmler, Sebastian, Ostwald, Dennis, Duenzinger, Ulrich, Launonen, Aino, Thuresson, Per-Olof

Volltext

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial von Bug, Gesine, Burchert, Andreas, Nicolaus, Kroeger, Huenecke, Sabine, Duenzinger, Ulrich, Wolf, Andrea, Bader, Peter, Serve, Hubert, Ottmann, Oliver G.

Volltext

Long-Term Results of a Fast Transplant Versus a Classical Conditioning Strategy for Allogeneic Stem Cell Transplantation of High Risk Acute Myeloid Leukemia (AML) Patients von Duenzinger, Ulrich, Martin, Hans, Mousset, Sabine, Agip, Salem, Klein, Stefan A., Serve, Hubert, Bug, Gesine

Volltext

Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Trans... von Gueller, Saskia, Duenzinger, Ulrich, Wolf, Timo, Mousset, Sabine, Martin, Hans, Serve, Hubert, Bug, Gesine

Volltext

E$-theory is compactly assembled von Bunke, Ulrich, Duenzinger, Benjamin

Volltext bestellen

(E\)-theory is compactly assembled von Bunke, Ulrich, Duenzinger, Benjamin

Volltext